Determinantes sociales, clínicos y psicosociales asociados a hipertensión arterial no controlada en adultos mayores. Encuesta SABE Colombia 2016

Galvis-Acevedo, Sebastián; Candamil-Castillo, Andrés Felipe; Herrera-Murgueitio, Julián Alberto; Calzada-Gutiérrez, María Teresa

doi:10.1016/j.regg.2022.02.001

Cited by 1 publication

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among Colombian patients treated for hypertension, ~ 65% achieve BP control, but because many patients do not receive treatment, this equates to BP control in only ~ 39% of patients with hypertension [ 10 , 11 ]. In the 2016 Colombian National Survey of Health, Welfare and Aging, factors associated with poor BP control were age > 74 years and living in a rural area [ 24 ]. In low-income urban settings, poor BP control is associated with older age, concomitant diabetes, poor adherence to treatment, and poor advice about nonpharmacological therapies [ 10 ].…”

Section: Issues In Hypertension Managementmentioning

confidence: 99%

The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review

Molina de Salazar,

Coca,

Alcocer

et al. 2024

Am J Cardiovasc Drugs

View full text Add to dashboard Cite

Hypertension is a major risk factor for cardiovascular disease and the leading cause of death in Colombia. While the rate of hypertension awareness in Colombia is generally high, rates of treatment initiation, adherence, and blood pressure (BP) control are suboptimal. Major international hypertension guidelines recommend starting treatment with a combination of antihypertensive agents, and the use of a single-pill combination (SPC) to maximize adherence. In contrast, Colombian hypertension guidelines recommend starting treatment with diuretic monotherapy in most patients, and only initiating combination therapy in those with BP > 160/100 mmHg. Therefore, the aim of the current narrative review is to examine the rationale for using SPCs to treat hypertension in Colombia, in the context of the major issues for BP control there. There is evidence of widespread therapeutic inertia in hypertension management, particularly in primary care, in Colombia. Moreover, combination therapy, angiotensin-converting enzyme inhibitors, and long-acting calcium channel blockers, which are internationally recommended as first-line drug therapies, are underutilized there. Adherence to antihypertensive therapy is low in Colombia and may be enhanced by use of SPCs as well as better patient education and follow-up. While there are promising national initiatives to improve BP management, more needs to be done by individual physicians. Antihypertensive SPCs are available on the national essential medicines list and may help to overcome some of the problems with suboptimal adherence, therapeutic inertia, and low rates of BP control that contribute to the high cardiovascular death rate in Colombia.

show abstract